Boston Scientific

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Boston Scientific 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BSX

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. 

CEO
Michael F. Mahoney
CEOMichael F. Mahoney
Employees
59,000
Employees59,000
Headquarters
Marlborough, Massachusetts
HeadquartersMarlborough, Massachusetts
Founded
1979
Founded1979
Employees
59,000
Employees59,000

BSX Key Statistics

Market cap
62.67B
Market cap62.67B
Price-Earnings ratio
17.70
Price-Earnings ratio17.70
Dividend yield
—
Dividend yield—
Average volume
19.87M
Average volume19.87M
High today
$43.96
High today$43.96
Low today
$42.95
Low today$42.95
Open price
$43.56
Open price$43.56
Volume
17.94M
Volume17.94M
52 Week high
$105.65
52 Week high$105.65
52 Week low
$42.20
52 Week low$42.20

Stock Snapshot

As of today, Boston Scientific(BSX) shares are valued at $43.20. The company's market cap stands at 62.67B, with a P/E ratio of 17.70.

On 2026-10-02, Boston Scientific(BSX) stock moved within a range of $42.95 to $43.96. With shares now at $43.20, the stock is trading +0.6% above its intraday low and -1.7% below the session's peak.

Trading activity shows a volume of 17.94M, compared to an average daily volume of 19.87M.

The stock's 52-week range extends from a low of $42.20 to a high of $105.65.

The stock's 52-week range extends from a low of $42.20 to a high of $105.65.

BSX News

TipRanks 7h
Elutia receives $8M payment from Boston Scientific

Elutia (ELUT) has received the full $8M held in escrow in connection with the sale of its BioEnvelope business to Boston Scientific (BSX). The payment was made...

Zacks 2d
Boston Scientific's MedSurg Diversification Bolsters Growth Prospects - Zacks Investment Research

...

Boston Scientific's MedSurg Diversification Bolsters Growth Prospects - Zacks Investment Research
TipRanks 2d
Boston Scientific Files Motion to Dismiss Shareholder Securities Lawsuit

Boston Scientific Corporation (BSX) and several of its top executives have filed a motion to dismiss a securities fraud lawsuit brought by investors. The litiga...

Analyst ratings

82%

of 33 ratings
Buy
81.8%
Hold
18.2%
Sell
0%

More BSX News

Simply Wall St 3d
Boston Scientific Recalls StoneSmart Console As Arthur Butcher Moves To Advisor Role

Boston Scientific (NYSE:BSX) announced that Arthur C. Butcher will retire as Executive Vice President and Group President, MedSurg and Asia Pacific, and move in...

Boston Scientific Recalls StoneSmart Console As Arthur Butcher Moves To Advisor Role
Benzinga 3d
FDA Flags Boston Scientific Catheter Recall

The FDA recently announced that Boston Scientific Corp. (NYSE:BSX) is recalling all Imager II Angiographic Catheters. The medical device manufacturer issued an...

FDA Flags Boston Scientific Catheter Recall

People also own

Based on the portfolios of people who own BSX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.